AFT Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
AFT Pharmaceuticals has a total shareholder equity of NZ$73.9M and total debt of NZ$36.8M, which brings its debt-to-equity ratio to 49.8%. Its total assets and total liabilities are NZ$158.9M and NZ$85.0M respectively. AFT Pharmaceuticals's EBIT is NZ$19.5M making its interest coverage ratio 6. It has cash and short-term investments of NZ$6.2M.
Key information
49.8%
Debt to equity ratio
NZ$36.79m
Debt
Interest coverage ratio | 6x |
Cash | NZ$6.17m |
Equity | NZ$73.91m |
Total liabilities | NZ$84.97m |
Total assets | NZ$158.87m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AFP's short term assets (NZ$95.1M) exceed its short term liabilities (NZ$48.3M).
Long Term Liabilities: AFP's short term assets (NZ$95.1M) exceed its long term liabilities (NZ$36.6M).
Debt to Equity History and Analysis
Debt Level: AFP's net debt to equity ratio (41.4%) is considered high.
Reducing Debt: AFP's debt to equity ratio has reduced from 1416.8% to 49.8% over the past 5 years.
Debt Coverage: AFP's debt is well covered by operating cash flow (35.7%).
Interest Coverage: AFP's interest payments on its debt are well covered by EBIT (6x coverage).